A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031). [electronic resource]
Producer: 19980612Description: 3607-15 p. digitalISSN:- 0006-4971
- Acute Disease
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Double-Blind Method
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hospitalization -- statistics & numerical data
- Humans
- Infection Control
- Leukemia, Myeloid -- drug therapy
- Life Tables
- Middle Aged
- Neutropenia -- prevention & control
- Recombinant Proteins
- Remission Induction
- Safety
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.